Company: OFIX
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0000950170-25-061062
Chunk: 6

Company: Orthofix Medical Inc.
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 6
---
 CR-related matters provided by the Nominating, Governance, and Sustainability Committee

Compliance and Ethics Committee oversees and monitors a comprehensive, Company-wide compliance and ethics program

Corporate code of conduct enforced at all levels of the Company and its subsidiaries

Commitment to healthy company culture that strives to directly impact communities around the world through meaningful partnerships, our employee volunteer program Orthofix Gives Back , and charitable contributions

Ongoing commitment of resources to keep pace with evolving data privacy and cybersecurity industry practices and regulatory standards

Commitment to sustainable practices in our operations, manufacturing, and supply chain through the use of sustainable energy, waste reduction, and waste and equipment recycling

Annual Board and Board committee self-assessments

Board regularly reviews director and executive succession planning

Robust stock ownership guidelines for our executive officers and directors

Majority voting in the election of directors in uncontested elections

Structured director education and onboarding program

Shareholders owning at least 25% of our outstanding common stock may call a special meeting of shareholders

No shareholder rights plan (commonly referred to as a “poison pill”) or blank check preferred stock

Single class of shares with equal voting rights (no super voting share class)

No supermajority voting requirements to approve mergers or other business combination transactions

No political or Political Action Committee (“PAC”) contributions by the Company

TABLE OF CONTENTS

| About Voting                                                                                                |    | 1 |
| Security Ownership of Certain Beneficial Owners and Management and Related Shareholders                     |  5 |   |
| Delinquent Section 16(a) Reports                                                                            |  9 |   |
| Information About Our Executive Officers                                                                    | 10 |   |
| Information about Directors                                                                                 | 12 |   |
| Certain Relationships and Related Transactions                                                              | 27 |   |
| Compensation Discussion and Analysis                                                                        | 28 |   |
| Report of the Compensation and Talent Development Committee                                                 | 45 |   |
| Summary Compensation Table                                                                                  | 46 |   |
| Grants of Plan-Based Awards                                                                                 | 48 |   |
| Outstanding Equity Awards at Fiscal Year-End                                                                | 51 |   |
| Option Exercises and Stock Vested                                                                           | 54 |   |
| Potential Payments upon Termination or Change in Control                                                    | 54 |   |
| Pay Ratio Disclosure                                                                                        | 59 |   |
| Pay Versus Performance                                                                                      | 60 |   |
| Director Compensation                                                                                       | 65 |   |
| Equity Compensation Plan Information                                                                        | 68 |   |
|